Skip to main content
. 2019 Mar 26;13:278. doi: 10.3389/fnins.2019.00278

Figure 4.

Figure 4

Treatment of levocarnitine and aluminum chloride on glutathione (GSH) (A–F); in the prefrontal cortex (PFC) (A), striatum (ST) (B), parietal cortex (PC) (C), hypothalamus (HT) (D), hippocampus (HP) (E) and cerebellum (CB) (F). The groups were control, AlCl3 (aluminum chloride), AST (astaxanthin), AST+AlCl3 (aluminum chloride and astaxanthin) and AlCl3+LC (aluminum chloride and levocarnitine) and LC (levocarnitine). Data presented as mean ± SEM. n = 6 per group except AST (n = 3); and AlCL3+AST (n = 3); ∗∗∗p < 0.001, ∗∗p < 0.01, p < 0.05.